Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 1
2022 4
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year

Filters applied: . Clear all
Page 1
Conservative Surgery in cT4 Breast Cancer: Single-Center Experience in the Neoadjuvant Setting.
Franco A, Di Leone A, Fabi A, Belli P, Carbognin L, Gambaro E, Marazzi F, Mason EJ, Mulè A, Orlandi A, Palazzo A, Paris I, Rossi A, Scardina L, Terribile DA, Tiberi G, Giannarelli D, Scambia G, Masetti R, Franceschini G. Franco A, et al. Among authors: tiberi g. Cancers (Basel). 2023 Apr 25;15(9):2450. doi: 10.3390/cancers15092450. Cancers (Basel). 2023. PMID: 37173916 Free PMC article.
Prospective Study Investigating the Efficacy and Safety of a Scalp Cooling Device for the Prevention of Alopecia in Women Undergoing (Neo)Adjuvant Chemotherapy for Breast Cancer.
Carbognin L, Accetta C, Di Giorgio D, Fuso P, Muratore M, Tiberi G, Pavese F, D'Angelo T, Fabi A, Giannarelli D, Di Leone A, Magno S, Garganese G, Sanchez AM, Terribile DA, Franceschini G, Masetti R, Scambia G, Paris I. Carbognin L, et al. Among authors: tiberi g. Curr Oncol. 2022 Sep 30;29(10):7218-7228. doi: 10.3390/curroncol29100569. Curr Oncol. 2022. PMID: 36290846 Free PMC article.
BRCA Mutation Status in Triple-Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: A Pivotal Role for Treatment Decision-Making.
Pavese F, Capoluongo ED, Muratore M, Minucci A, Santonocito C, Fuso P, Concolino P, Di Stasio E, Carbognin L, Tiberi G, Garganese G, Corrado G, Di Leone A, Generali D, Fragomeni SM, D'Angelo T, Franceschini G, Masetti R, Fabi A, Mulè A, Santoro A, Belli P, Tortora G, Scambia G, Paris I. Pavese F, et al. Among authors: tiberi g. Cancers (Basel). 2022 Sep 21;14(19):4571. doi: 10.3390/cancers14194571. Cancers (Basel). 2022. PMID: 36230495 Free PMC article.
Assessing the pathogenicity of BRCA1/2 variants of unknown significance: Relevance and challenges for breast cancer precision medicine.
De Paolis E, Paris I, Tilocca B, Roncada P, Foca L, Tiberi G, D'Angelo T, Pavese F, Muratore M, Carbognin L, Garganese G, Masetti R, Di Leone A, Fabi A, Scambia G, Urbani A, Generali D, Minucci A, Santonocito C. De Paolis E, et al. Among authors: tiberi g. Front Oncol. 2023 Jan 18;12:1053035. doi: 10.3389/fonc.2022.1053035. eCollection 2022. Front Oncol. 2023. PMID: 36741700 Free PMC article.